Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

1(50.0%)

Phase 4

1(50.0%)

2Total

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT05484960Unknown

The Philippine Neurological Association One Database -Dementia

Role: collaborator

NCT05096312Phase 4Completed

Effects of Oral Zinc Gluconate Among Acne Vulgaris Patients

Role: lead

NCT04975412Completed

Relationship of Whole Blood Zinc Levels to Acne Severity

Role: lead

NCT04491656Not ApplicableCompleted

Evaluating Clinical Outcomes for Determining the Optimal Delay to Skin Incision Under WALANT

Role: lead

NCT04386083Unknown

Neurologic Manifestations of COVID-19

Role: collaborator

All 5 trials loaded